$インビビッド(IVVD.US)$Benzinga· just Invivyd To Pursue Rapid Immunobridging Pathway To Potential EUA For Treatment Of COVID-19 In Moderately To Severely Immunocompromised People, Based On U.S. FDA Feedback
$インビビッド(IVVD.US)$Invivyd Receives Healthcare Common Procedure Coding System (Hcpcs) Reimbursement Codes From the U.S. Centers for Medicare & Medicaid Services (CMS) Covering Pemgarda™
$インビビッド(IVVD.US)$Invivyd Shares Are Trading Higher After the Company Announced PEMGARDA Is Available for Purchase in the U.S. and Said It Sees Initial FY24 PEMGARDA Net Product Revenue Guidance in the Range of $150 Million to $200 Million
2
1
報告
Trytosaveabitスレ主 :
This news was released right at regular market close at 4PM est last evening
WhisprRiveraスレ主:
Oh brother I can not tell you leagally what is right or wrong. Im simply stating what I do, but in no way should you take me, verbally proccessing as advice plz.
インビビッドに関するコメント
Invivyd To Pursue Rapid Immunobridging Pathway To Potential EUA For Treatment Of COVID-19 In Moderately To Severely Immunocompromised People, Based On U.S. FDA Feedback
まだコメントはありません